FDA Commissioner Faces Pressure To Limit Abortion Pill After Study Finds Increased Risks
This isn’t the first time Makary has encountered questions about the status of mifepristone under his leadership....
All Rights Reserved. Copyright , Central Coast Communications, Inc.